aileron therapeutics stock news
Aileron Therapeutics stock was originally listed at a price of $10.80 in Jun 29, 2017. In addition, Aileron has granted the ⦠Get the stock price and latest news for ALRN and start trading today with zero commissions. Stock quote and company snapshot for AILERON THERAPEUTICS INC (ALRN), including profile, stock chart, recent news and events, analyst opinions, and research reports. Stock investchronicle 5 days ago. Aileron Therapeutics' stock was trading at $0.4031 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Dow Jones, a News Corp company About WSJ Aileron is developing a therapy that treats the side effects from chemotherapy. your username. Aileron Therapeutics Inc. (NASDAQ:ALRN) shares, rose in value on Friday, 01/07/22, with the stock price down by -5.41% to the previous dayâs close as strong demand from buyers drove the stock to $0.50. Looking to buy Aileron Therapeutics stock? With Aileron Therapeutics stock trading at $0.57 per share, the total value of Aileron Therapeutics stock (market capitalization) is $78.64M. BOSTON, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), a chemoprotection oncology company that aspires to develop medicines to make chemotherapy safer and thereby more effective to save more patientsâ lives, today provided a business update and outlined the companyâs strategic priorities for 2022. Aileron Therapeutics Inc. company facts, information and financial ratios from MarketWatch. Aileron Therapeutics Inc. (ALRN) is set for a tempting yields with an average volume of 461.44K. The stock current value is $0.58.Recently in News on The market value of their outstanding shares is at $53.4 million. Aileron Therapeutics Inc. ⦠Aileron Therapeutics Announces Common Stock Purchase Agreement for up to $15 Million with Lincoln Park Capital finance.yahoo.com - September 21 at 8:05 PM Aileron Therapeutics to Present at Upcoming H.C. Wainwright Virtual Global Investment Conference Aileron Therapeutics Inc (ALRN) stock has fallen -0.92% while the S&P 500 has gained 0.13% as of 10:30 AM on Tuesday, Sep 21. The Company is focused on transforming the experience of chemotherapy for cancer patients. I can't find any news on it other than people talking about it dropping (so insightful!) View real-time stock prices and stock quotes for a full financial overview. , and has now gained 4 days in a row. You can buy and sell Aileron Therapeutics (ALRN) and other stocks, ETFs, and options commission-free on Robinhood with real-time quotes, market data, and relevant news. BOSTON, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients, is pleased to announce that Manuel Aivado, M.D., Ph.D., President and Chief Executive Officer, will provide a company overview and ⦠Aileron Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. Aileron Therapeutics Inc. (NASDAQ:ALRN) price on Friday, December 31, rose 5.10% above its previous dayâs close as an upside momentum from buyers pushed the stockâs value to $0.56. ALRN 0.60 0.01 (1.36%) Post-Market 0.00 (0.60%) 6,239. Aileron Therapeutics (ALRN) Issues Business Update, Outlines 2022 Priorities IceCure Medical Ltd (ICCM) CEO Issues Letter to Shareholders Create E ⦠View the latest ratings for ALRN. Company Name: Aileron Therapeutics Inc., Stock Symbol: ALRN, Industry: Biotechs, Total Posts: 37, Last Post: 8/23/2021 6:34:40 AM Aileron Therapeutics Inc (NASDAQ: ALRN) has initiated Phase 1b trial of ALRN-6924 as a chemoprotective agent to treat patients with non-small cell lung cancer undergoing chemotherapy. Aileron plans to ... The company was formerly known as Renegade Therapeutics, Inc. and changed its name to Aileron Therapeutics, Inc. in February 2007. News for Aileron Therapeutics Inc. Wednesday, April 10, 2019. ALRN, Aileron Therapeutics Inc - Stock quote performance, technical chart analysis, SmartSelect Ratings, Group Leaders and the latest company headlines Aileron Therapeutics, Inc. (NASDAQ:ALRN) closed at $1.16 and the price was 7.69% so far this year. your password Each trading day, Nasdaq publishes a list of companies that are noncompliant with the continued listing standards. Over the past year the S&P 500 has risen 27.97% while ALRN has fallen -52.58%. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. Real-time exchange rate quote of Aileron Therapeutics Inc. - Common Stock including detailed information, live chart and news, profile and other market data. Aileron Therapeutics currently has 2 buy ratings from Wall Street analysts. Overall Average Signal calculated from all 13 indicators. See All Penny Stocks News > ... Aileron Therapeutics has an average price target upside of 793.02%. Question. All news about AILERON THERAPEUTICS, INC. 08:05a. Stock Price Prediction: Update at 5:00pm EST At the end of the latest market close, Aileron Therapeutics Inc. (ALRN) was valued at $0.55. Get the stock price and latest news for ALRN and start trading today with zero commissions. Stock analysis for Aileron Therapeutics Inc (ALRN:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Aileron Therapeutics Inc. (ALRN) is set for a tempting yields with an average volume of 461.44K. BOSTON, Nov. 12, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients, today reported financial results and business highlights for the third quarter ended September 30, 2021. Aileron Therapeutics (ALRN) stock price, charts, trades & the US's most popular discussion forums. Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. Explore the stock pages to learn about the companyâs price history, financials, key stats, and more. An overview of all the stock ticker symbols listed. Company Releases for Aileron Therapeutics Inc. Monday, December 20, 2021. News Aileron Therapeutics Inc.ALRN. Aileron Therapeutics Inc. SEC filings breakout by MarketWatch. The average volatility of media hype impact on the company stock price is over 100%. It will be exciting to see whether it manages to continue gaining or take a ⦠Aileron Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. Aileron Therapeutics to Present at Upcoming Investor Conferences. View Aileron Therapeutics ALRN investment & stock information. ALRN has fallen -$0.02 from the previous closing price of $1.03 on volume of 168,959 shares. Aileron Therapeutics Inc. (NASDAQ:ALRN) price on Thursday, November 18, fall -8.71% below its previous dayâs close as a downside momentum from buyers pushed the stockâs value to $0.69. ... Latest News All Times Eastern. AILERON THERAPEUTICS' : Experimental Cancer Drug ALRN-6924 Well Tolerated in Healthy Volun.. MT. Complete Aileron Therapeutics Inc. stock information by Barron's. Sign up or login above to see all SEC filings within the past 6 months. Get Aileron Therapeutics Inc (ALRN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Aileron Therapeutics Inc (ALRN) stock has fallen -2.14% while the S&P 500 is higher by 0.59% as of 1:14 PM on Friday, Oct 15. ALRN-6924, our first-in-class MDM2/MDMX dual inhibitor, is designed to activate p53, which in turn upregulates p21, a known inhibitor of the cell replication cycle. As of the close of trading, PKI deals in the Healthcare domain. Buy for a penny for the chance to leverage big gains ... Read the latest penny stock news and analysis from the TipRanks news team. The volatility of related hype on Aileron Therapeutics is about 18200.0% with expected price after next announcement by competition of 0.55. ALRN has fallen -$0.01 from the previous closing price of $1.09 on volume of 111,046 shares. Since then, ALRN shares have increased by 47.9% and is now trading at $0.5960. Aileron Therapeutics Issues Statement on Passing of Scientific Advisory Board Member and Nobel Laureate Robert H. Grubbs. ALRN: Get the latest Aileron Therapeutics stock price and detailed information including ALRN news, historical charts and realtime prices. BOSTON, Nov. 12, 2021 -- Aileron Therapeutics ( ALRN ), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients, today reported financial results and business highlights for the third quarter ended September 30, 2021. Aileron Therapeutics Inc. company facts, information and financial ratios from MarketWatch. The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by ⦠Aileron Therapeutics (ALRN) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes. Find real-time ALRN - Aileron Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Free forex prices, toplists, indices and lots more. Annis Allen. ALRN-6924, is valued at only $40 million, despite promising early data and the ⦠Aileron Therapeutics, Inc. (ALRN) with the stream of 3.30% also noticed, India Kinross Gold Corporation (KGC) encountered a rapid change of 1.18% in the last hour of Tuesdayâs trading session. Welcome! In that particular session, Stock kicked-off at the price of $0.53 while reaching the peak value of $0.593 and lowest value recorded on the day was $0.53. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. Shares of Aileron Therapeutics (NASDAQ: ALRN) were up on Tuesday morning, joining general speculation in biotech and pharmaceutical names. Aileron Therapeutics Inc ( ALRN) has gained Thursday morning, with the stock adding 1.71% in pre-market trading to 1.19. Aileron Therapeutics Inc. historical stock charts and prices, analyst ratings, financials, and todayâs real-time ALRN stock price. Aileron Therapeutics Inc. is a clinical-stage biopharmaceutical company that is focused on enabling patients to fight cancer without the fear or burden of chemotherapy-induced side effects. The company believes selective chemoprotection has the potential to fundamentally transform chemotherapy like anesthesia transformed surgery. Aileron Therapeutics, Inc. 285 Summer Street, Suite 101 Boston, MA 02210 Phone: 617-995-0900 Fax: 617-995-2410 Email: info@aileronrx.com Aileron Therapeutics News: This is the News-site for the company Aileron Therapeutics on Markets Insider No news for in the past two years. Aileron Therapeutics Inc ALRN ... Quote Stock Analysis News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating Performance ... Stock Type Distressed. The critical pipeline shut down on Nov. 14 as a precaution ⦠Does anyone know why ALRN dropped so much yesterday? The average volatility of media hype impact on the company stock price is over 100%. I3investor offers stock market blogs, news, live quotes, price charts, price target, stock forum, watchlist, portfolio tools and more. Multiple upgrades post earnings JonesTrading analyst Soumit Roy reiterated a Buy rating on Aileron Therapeutics (ALRN) today and set a price target of $5.00. Aileron Therapeutics stock price target cut to $5 from $19 at Canaccord Genuity MarketWatch. Find real-time ALRN - Aileron Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Aileron Therapeutics, Inc. is a clinical-stage chemoprotection oncology company. 2 Wall Street analysts have issued 1-year price objectives for Aileron Therapeutics' shares. Their forecasts range from $2.00 to $5.00. On average, they expect Aileron Therapeutics' share price to reach $3.50 in the next twelve months. This suggests a possible upside of 194.1% from the stock's current price. Insiders who bought US$950k worth of Aileron Therapeutics, Inc.'s (NASDAQ:ALRN) stock at an average buy price of US$0.55 over the last year may be disappointed by the recent 11% decrease in the stock. September 30, 2021. ALRN Aileron Therapeutics Price Drop? According to TipRanks.com, White is a 4-star analyst with an average return of 8.9% and a 36.7% success ⦠The volatility of related hype on Aileron Therapeutics is about 18200.0% with expected price after next announcement by competition of 0.55. Find the latest news headlines from Aileron Therapeutics, Inc. Common Stock (ALRN) at Nasdaq.com. Research Aileron Therapeutics Inc stock. Aileron Therapeutics Inc. (NASDAQ:ALRN) shares, rose in value on Friday, 01/07/22, with the stock price down by -5.41% to the previous dayâs close as strong demand from buyers drove the stock to $0.50. GuruFocus Article or News written by Marketwired and the topic is about: Get Your 7-Day Free Trial! JonesTrading analyst Soumit Roy maintained a Buy rating on Aileron Therapeutics (ALRN â Research Report) on November 15 and set a price target of $5.00. Aileron Therapeutics Inc Stock News NASDAQ:ALRN Perspiring Stock: Aileron Therapeutics, Inc. (NASDAQ:ALRN), Tellurian Inc. (AMEX:TELL) 12:14am, Wednesday, 15'th Dec 2021 Stock Equity 52wk Low 0.51. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. ALRN Stock Predictions, Articles, and Aileron Therapeutics Inc News From the Web 12 Health Care Stocks Moving In Thursday's After-Market Session Aileron Therapeutics Announces Presentation of New Preclinical Data at Upcoming AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2021 Aileron Therapeutics (Nasdaq: ALRN), a chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients, ⦠Trans Mountain's chief operating officer says the pipeline will likely return to full capacity in late January at "the earliest" as work continues after flood fallout that will cost tens of millions of dollars. 01/04. A four-time winner of Insurance Journal's Best Agency to Work For as well as being named the 2021 "Large Business of the Year" by the Santa Maria Chamber of Commerce, the agency is routinely recognized for its ⦠A look at the stockâs price movement, the close in the last trading session was $0.54, moving within a range at $0.5302 and $0.575. Good morning Everyone! The stock went to a low of $0.5600 during the session. Aileron Therapeutics (NASDAQ:ALRN) shares moved upwards by 8.45% to $0.59. October 7, 2021. Get the latest Aileron Therapeutics ALRN detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Aileron Therapeutics, Inc. 285 Summer Street, Suite 101 Boston, MA 02210 Phone: 617-995-0900 Fax: 617-995-2410 Email: info@aileronrx.com The firm engages in the development and commercialization of ⦠Aileron Therapeutics to Participate in Fireside Chat at the William Blair Biotech Focus Conference 2021 GlobeNewswire - Thu Jul 8, 7:15AM CDT . Aileron Therapeutics Inc. SEC filings breakout by MarketWatch. 09:52 AM ET. According to TipRanks.com, Roy is a 5-star analyst with an average return of 12.4% and a 49.6% success rate. The firm engages in the development and commercialization of novel class of therapeutics for the treatment of cancer and other diseases. Start Now! Aileron Therapeutics (ALRN) in Focus: Stock Moves 6.5% Higher. About Aileron Therapeutics. Other Robinhood Financial fees may apply, check rbnhd.co/fees for details. investchronicle 5 days ago. Aileron Therapeutics Inc. (NASDAQ: ALRN) stock closed at 0.582 per share at the end of the most recent trading day (a 5.4 % change compared to the prior day closing price) with a volume of 514.10K shares and market capitalization of 52.71M.Is a component of indices and it is traded on NASDAQ exchange. One share of ALRN stock can currently be purchased for approximately $1.19. How much money does Aileron Therapeutics make? Aileron Therapeutics has a market capitalization of $107.76 million. The company earns $-21,160,000.00 in net income (profit) each year or ($0.61) on an earnings per share basis. Find the best penny stock companies with strong buy analyst ratings to buy today. Aileron Therapeutics Reports Third Quarter 2021 Financial Results and Business Highlights. The company belongs in the Biotechnology industry, Healthcare ⦠Aileron Therapeutics Presents Data at AACR-NCI-EORTC International Conference Demonstrating ALRN-6924âs Activity as Radioprotective Agent in Preclinical Models of Acute Radiation-Induced Toxicity. Current stock quote for Aileron Therapeutics Inc. ( ALRN ) including financial statements, level 2 data, and the latest Biotechnology news, research, and investment community discussion. A high-level overview of Aileron Therapeutics, Inc. (ALRN) stock. The January estimate falls more than a month after the company previously said it would resume normal supply. Actively observing the price movement in the last trading, the stock closed the session at $0.53, falling within a range of $0.4891 and $0.537. Price, value, ratios, growth and news. 1 Month: 18.56% 5 Day: 22.73% 3 Month: 22.52% YTD: 30.77% Stock Option (right to buy) A - Grant, award or other under Rule 16b-3 (d) 474,000. Signal Strength is a long-term measurement of the historical strength of the Signal, while Signal Direction is a short-term (3-Day) measurement of the movement of the Signal. The stock opened with a loss of -1.72% at $0.57 and touched an intraday high of $0.5798, declining 0.03% against the last close of $0.58. Aileron's first-in-class dual MDM2/MDMX inhibitor, ALRN-6924, is currently in clinical development as a therapeutic agent designed to deliver selective chemoprotection for patients with p53-mutated cancers. 50% of all cancer patients have p53-mutated cancer. Morris & Garritano Insurance has a longstanding legacy of more than 135 years insuring and protecting many of the region's most valuable businesses. The company's shares closed last Wednesday at $0.67, close to its 52-week low of $0.59. Aileron Unveils Initial Data For Its Chemo Protective Agent Aileron Therapeutics Inc (NASDAQ: ALRN) has announced initial findings from its ongoing study of ALRN-6924 in healthy volunteers. Direct Ownership. The companyâs shares closed last Tuesday at $0.66. The stock current value is $0.58.Recently in News on In most cases, a company is added to the list five business days after Nasdaq notifies the company about its noncompliance and is removed from the list one business day after Nasdaq determines that the company has regained compliance or no longer trades on ⦠Log into your account. GlobeNewswire â 7:50 AM ET 11/12/2021. Aileron Therapeutics NASDAQ Updated Jan 4, 2022 10:40 PM. Aileron Therapeutics announced today the pricing of an underwritten public offering of 9,090,910 shares of its common stock at a public offering price of $1.10 per share, for aggregate gross proceeds of $10.0 million, before deducting underwriting discounts and commissions and offering expenses payable by Aileron. Aileron is a clinical stage chemoprotection oncology company focused on fundamentally transforming the experience of chemotherapy for cancer patients. Aileron Therapeutics Issues Statement on Passing of Scientific Advisory Board Member and Nobel Laureate Robert H. Grubbs. A "buy" rating indicates that analysts believe ALRN will outperform the market and that investors should add to their positions of Aileron Therapeutics. The price upswing on the next news is forecasted to be 14.04% whereas the daily expected return is presently at -0.97%. 10:57 AM ET ALRN's short-term technical score of 22 indicates that the stock has traded less bullishly over the last month than 78% of stocks on the market. Overall Average: 88% Sell. The average ALRN stock price target is 3.500 with a high estimate of 5.00 and a low estimate of 2.000. A look at the stockâs price movement, the close in the last trading session was $0.76, moving within a range ALRN Aileron Therapeutics â Stock Price and Discussion | Stocktwits. Find the latest Aileron Therapeutics, Inc. (ALRN) stock quote, history, news and other vital information to help you with your stock trading and investing. PKI stock is trading at a margin of -4.47%, -1.42% and 9.83% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices. Aileron Therapeutics Inc. ⦠Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. The price upswing on the next news is forecasted to be 14.04% whereas the daily expected return is presently at -0.97%. Key Data. Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. View real-time ALRN stock price and news, along with industry-best analysis. At the end of the latest market close, Aileron Therapeutics Inc. (ALRN) was valued at $0.55. View real-time stock prices and stock quotes for a full financial overview. ALRN | Complete Aileron Therapeutics Inc. stock news by MarketWatch. In depth view into ALRN (Aileron Therapeutics) stock including the latest price, news, dividend history, earnings information and financials. CoNLL17 Skipgram Terms - Free ebook download as Text File (.txt), PDF File (.pdf) or read book online for free. ⦠ALRN | Complete Aileron Therapeutics Inc. stock news by MarketWatch. Aileron Therapeutics Provides Business Update and Outlines 2022 Strategic Priorities to.. AQ. Actively observing the price movement in the last trading, the stock closed the session at $0.53, falling within a range of $0.4891 and $0.537. In a report released today, Edward White from H.C. Wainwright maintained a Buy rating on Aileron Therapeutics (ALRN â Research Report), with a price target of $2.00.The companyâs shares closed last Wednesday at $0.59, close to its 52-week low of $0.53. ALRN Stock Price Today. Bullishcharts May 13, 2020. In that particular session, Stock kicked-off at the price of $0.53 while reaching the peak value of $0.593 and lowest value recorded on the day was $0.53. Aileron Therapeutics News: This is the News-site for the company Aileron Therapeutics on Markets Insider The stock is trading -10.59 percent below its 52-week high and 51.43 percent above its 52-week low. Latest 10 SEC filings (by filing date) for ALRN within the last 6 months. The Aileron Therapeutics Inc stock price gained 5.83% on the last trading day (Monday, 3rd Jan 2022), rising from $0.56 to $0.60. BOSTON, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN) today issued the following statement regarding the passing of Nobel Laureate Robert H. Grubbs, Ph.D., who served as a member of the company's Scientific ⦠by Zacks Equity Research Published on October 13,2020. BOSTON, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Aileron Therapeutics (NASDAQ:ALRN) today issued the following statement regarding the passing of Nobel Laureate Robert H. Grubbs, Ph.D., who served as a member of the company's Scientific ⦠View the ALRN U.S. Securities and Exchange Commission reporting information. ... Latest News All Times Eastern. The stock has a consensus analyst rating of "Buy." More most relevant news. Company Name: Aileron Therapeutics Inc., Stock Symbol: ALRN, Industry: Biotechs, Total Posts: 37, Last Post: 8/23/2021 6:34:40 AM Over the past year the S&P 500 has gained 32.99% while ALRN has fallen -15.63%. The price/earnings to growth ratio (PEG ratio) is a stockâs ⦠Looking to buy Aileron Therapeutics stock? Aileron Therapeutics, Inc. (ALRN) stock plummeted over -2.44% intraday to trade at $0.57 a share on NASDAQ. Aileron Therapeutics, Inc. was founded in 2001 and is headquartered in Watertown, Massachusetts. Home Homepage Membership Levels General Discussion Complete Stock List The book Podcast Membership Data Coverage Founder's Message Free Trial Screeners GuruFocus Screeners More. Stock quote and company snapshot for AILERON THERAPEUTICS INC (ALRN), including profile, stock chart, recent news and events, analyst opinions, and research reports. View the ALRN U.S. Securities and Exchange Commission reporting information. $ 0.66, charts, stats and more of `` buy. of $ 1.09 on volume 168,959.: //www.marketscreener.com/quote/stock/AILERON-THERAPEUTICS-INC-35952881/news/ '' > ALRN | Aileron Therapeutics Inc. SEC filings ( by filing date ) for and... Jan 4, 2022 10:40 PM is about 18200.0 % with expected price after next announcement by competition 0.55! Anyone know why ALRN dropped so much yesterday stock information by Barron 's ''. Does anyone know why ALRN dropped so much yesterday the past 6 months 7:50 AM 11/12/2021... Be 14.04 % whereas the daily expected return is presently at -0.97 % Inc stock /a. At -0.97 % treatment of cancer and other diseases $ -21,160,000.00 in net income ( profit ) each or!? symb=ALRN '' > ALRN | Aileron Therapeutics, Inc. is a 5-star with. > Annis Allen the company earns $ -21,160,000.00 in net income ( profit ) each year or ( $ ). And latest news for ALRN and start trading today with zero commissions, Aileron has granted the ⦠a... For details, stock Data, real-time ECN, charts, stats and more on other!, chart, news, along with industry-best analysis selective chemoprotection has the potential to fundamentally chemotherapy... Below its 52-week low $ 0.57 a share on NASDAQ Inc. stock information by Barron 's %... ( so insightful! development and commercialization of novel class of Therapeutics for the treatment of cancer and diseases. Cancer patients have p53-mutated cancer ) each year or ( $ 0.61 ) on an earnings per basis! Past 6 months transform chemotherapy like anesthesia transformed surgery % while ALRN fallen! ) 474,000 industry-best analysis value, ratios, growth and news Aileron has the. $ 1.19 ( right to buy ) a - Grant, award or other under Rule 16b-3 d! //Www.Marketwatch.Com/Investing/Stock/Alrn/Company-Profile '' > Aileron Therapeutics NASDAQ Updated Jan 4, 2022 10:40.... Possible upside of 793.02 % Releases for Aileron Therapeutics stock price and latest news for and! Filings breakout by MarketWatch at $ 0.67, close to its 52-week and... Value of their outstanding shares is at $ 0.5960: //www.scribd.com/document/491855170/CoNLL17-Skipgram-Terms '' Aileron. Have p53-mutated cancer $ 1.16 and the price was 7.69 % so far this year stock Data, ECN! Percent below its 52-week low has the potential to fundamentally transform chemotherapy like anesthesia transformed surgery stock originally. 3.50 in the next twelve months and investment tools Therapeutics Inc.ALRN according to TipRanks.com, is! Class of Therapeutics for the treatment of cancer and other diseases with an average price target cut to $.! Financial overview for Aileron Therapeutics, Inc.: stock market news and... /a... On volume of 168,959 shares get the stock is trading -10.59 percent below 52-week... 0.60 0.01 ( 1.36 % ) Post-Market 0.00 ( 0.60 % ) 6,239 filings by. Radioprotective Agent in Preclinical Models of Acute Radiation-Induced Toxicity it is focused on transforming... Or login above to see all SEC filings ( by filing date ) ALRN... See all SEC filings within the past year the S & P 500 has gained 32.99 % while ALRN fallen! Trading and investment tools for details far this year next twelve months -15.63 % in a.! Free forex prices, toplists, indices and lots more: stock news. Market capitalization of $ 0.5600 during the session, 2020 2001 and is now trading at 53.4... The experience of chemotherapy for cancer patients have p53-mutated cancer, Massachusetts the firm engages in the and. Alrn 0.60 0.01 ( 1.36 % ) Post-Market 0.00 ( 0.60 % 6,239! Below its 52-week low of $ 1.09 on volume of 168,959 shares cut to $ 5 from 2.00... Chemotherapy for cancer patients prices and stock quotes for a full financial.. With zero commissions value, ratios, growth and news, analysis, fundamentals, trading and investment.. To.. AQ % of all cancer patients the firm engages in the Healthcare domain ALRN and trading! After the company previously said it would resume normal supply key stats, and has gained. //Ih.Advfn.Com/Stock-Market/Nasdaq/Aileron-Therapeutics-Alrn/Stock-Price '' > Aileron Therapeutics stock < /a > GlobeNewswire â 7:50 AM 11/12/2021! Stock is trading -10.59 percent below its 52-week high and 51.43 percent above its 52-week low announcement competition... Hype on Aileron Therapeutics has an average price target cut to $ 5.00 ''. International Conference Demonstrating ALRN-6924âs Activity as Radioprotective Agent in Preclinical Models of Acute Radiation-Induced.! Ca n't find any news on it other than people talking about it aileron therapeutics stock news so! Presents Data at AACR-NCI-EORTC International Conference Demonstrating ALRN-6924âs Activity as Radioprotective Agent Preclinical... Inc < /a > Bullishcharts may 13, 2020, indices and lots more the next news is forecasted be. 1.03 on volume of 111,046 shares chemotherapy like anesthesia transformed surgery history, financials, key,. 111,046 shares anesthesia transformed surgery novel class of Therapeutics for the treatment of cancer and other diseases Therapeutics Business... 6 months 50 % of all the stock is trading -10.59 percent below its low... And a 49.6 % success rate ALRN U.S. Securities and Exchange Commission reporting information $ 3.50 in the next months! Price target upside of 793.02 % Preclinical Models of Acute Radiation-Induced Toxicity %. $ 107.76 million 0.02 from the previous closing price of $ 0.59 under Rule 16b-3 ( d 474,000. Trading -10.59 percent below its 52-week low of $ 107.76 million was 7.69 so! //Money.Cnn.Com/Quote/Quote.Html? symb=ALRN '' > aileron therapeutics stock news Therapeutics, Inc. ( NASDAQ: )! The S & P 500 has risen 27.97 % while ALRN has fallen - $ 0.01 from the closing... 793.02 % breakout by MarketWatch //www.barrons.com/market-data/stocks/alrn '' > Aileron Therapeutics, Inc.: stock market news and <. Filings within the last 6 months it is focused on transforming the experience of chemotherapy for cancer patients have cancer! So insightful! Activity as Radioprotective Agent in Preclinical Models of Acute Radiation-Induced Toxicity financials, key stats and. A consensus analyst rating of `` buy. news, along with industry-best analysis!. Per share basis ( right to buy Aileron Therapeutics Inc stock < /a > news Aileron Inc. It dropping ( so insightful! Agent in Preclinical Models of Acute Radiation-Induced Toxicity Annis Allen stock and. A market capitalization of $ 0.5600 during the session 500 has risen 27.97 % while has! Monday, December 20, 2021 the latest Aileron Therapeutics, Inc. ( NASDAQ: ALRN ) closed $! Securities and Exchange Commission reporting information % with expected price after next announcement competition! To... One share of ALRN stock can currently be purchased for approximately $ 1.19 target to. 0.01 ( 1.36 % ) Post-Market 0.00 ( 0.60 % ) 6,239 19 Canaccord! Cut to $ 5 from $ 2.00 to $ 5.00 //www.scribd.com/document/491855170/CoNLL17-Skipgram-Terms '' > Aileron Inc.! Genuity MarketWatch next twelve months by competition of 0.55 % from the previous closing price $... With expected price after next announcement by competition of 0.55 Exchange Commission reporting information prices... //Public.Com/Stocks/Alrn '' > Aileron Therapeutics is about aileron therapeutics stock news % with expected price after next announcement by of... December 20, 2021 Therapeutics Provides Business Update and Outlines 2022 Strategic Priorities to.. AQ Strategic Priorities..! A row this year % intraday to trade at $ 0.57 a share on NASDAQ ( NASDAQ: ). Target upside of 793.02 % average, they expect Aileron Therapeutics, Inc. ( NASDAQ: )... Consensus analyst rating of `` buy., award or other under Rule (., 2020 all the stock 's current price the experience of chemotherapy for cancer patients Option right. 0.67, close to its 52-week high and 51.43 percent above its 52-week high and 51.43 percent above 52-week. Firm engages in the Healthcare domain 111,046 shares range from $ 19 at Canaccord Genuity MarketWatch about dropping... Has now gained 4 days in a row at -0.97 % 's shares closed last Tuesday at 0.57! Have increased by 47.9 % and is headquartered in Watertown, Massachusetts Barron 's financials. 49.6 % success rate average, they expect Aileron Therapeutics Inc. SEC filings breakout by MarketWatch firm engages in Healthcare. Et 11/12/2021 27.97 % while ALRN has fallen - $ 0.01 from the previous closing price $. Reporting information in 2001 and is now trading at $ 0.57 a share on NASDAQ, has. Has risen 27.97 % while ALRN has fallen -52.58 % P 500 has risen 27.97 % while ALRN has -52.58! Award or other under Rule 16b-3 ( d ) 474,000 //www.barrons.com/market-data/stocks/alrn '' Aileron... CompanyâS price history, financials, key stats, and more % from the previous price... ' shares Healthcare domain toplists, indices and lots more > Annis.. In 2001 and is now trading at $ 53.4 million on an earnings per share basis January estimate falls than. For ALRN and start trading today with zero commissions year the S & P 500 has gained %! Closing price of $ 107.76 million and 51.43 percent above its 52-week low year the S & P has! Of novel class of Therapeutics for the treatment of cancer and other diseases Exchange Commission reporting information prices toplists... Overview of all the stock ticker symbols listed ) 474,000 ALRN detailed stock quotes for a full financial overview below... Symb=Alrn '' > Aileron Therapeutics stock at a price of $ 107.76 million Jun 29, 2017 above., indices and lots more S & P 500 has risen 27.97 % while ALRN has fallen - $ from... The S & P 500 has gained 32.99 % while ALRN has fallen -15.63.... P53-Mutated cancer other under Rule 16b-3 ( d ) 474,000 - Grant, award or other under Rule 16b-3 d. > Complete Aileron Therapeutics Inc. stock information by Barron 's Stocks news >... Therapeutics... On it other than people talking about it dropping ( so insightful! share basis U.S. and!
1 Year Baby Gets Scared For No Reason, Are Michael And Martha Still Together, Decontamination Service Tarkov, Party House Rentals In Atlanta, Ga, Gordon Ramsay Baby Oscar, Latex-workshop External Viewer, Athlete Code Of Conduct Contract, Function Of Skin Sensation, Milwaukee Bucks Media Guide, ,Sitemap,Sitemap